The GAD-7 is a validated, public-domain screening questionnaire for generalized anxiety symptoms, developed by Spitzer, Kroenke, Williams, and Löwe. It is a screening aid, not a diagnosis — only a qualified clinician can diagnose an anxiety disorder.
Over the last 2 weeks, how often have you been bothered by the following problems?
About this tool: the GAD-7 (Generalized Anxiety Disorder 7-item scale) is a validated, public-domain screening instrument widely used in primary care. Scoring: 0-4 minimal, 5-9 mild, 10-14 moderate, 15-21 severe. It screens for symptom severity — it cannot diagnose an anxiety disorder, rule out other conditions, or replace a conversation with a clinician. See our medical disclaimer.
Understanding anxiety screening and the GAD-7
Generalized anxiety involves persistent, excessive worry that's hard to control and interferes with daily life — distinct from normal, situational stress. The GAD-7 is one of the most widely used anxiety screening tools in primary care and mental health settings worldwide, valued for being quick, free, and clinically validated across many studies and populations.
Related reading
- PHQ-9 Depression Screening Tool
- Meditation Benefits: The Complete Guide
- Daith Piercing for Anxiety: What the Evidence Says
- All mental health & mindfulness articles
Frequently asked questions
Can the GAD-7 diagnose an anxiety disorder?
No. The GAD-7 is a screening tool that measures symptom severity over the past 2 weeks — it flags whether further evaluation may be worthwhile, but only a qualified clinician can diagnose generalized anxiety disorder or any other condition.
What score on the GAD-7 suggests I should talk to someone?
A score of 10 or above is commonly used as a reasonable threshold to discuss the results with a doctor or mental health professional, though any score alongside symptoms that bother you or affect your life is worth mentioning, regardless of the number.
How is the GAD-7 different from the PHQ-9?
The GAD-7 screens specifically for generalized anxiety symptoms, while the PHQ-9 screens for depression symptoms. Anxiety and depression frequently co-occur, so some clinicians use both tools together for a fuller picture.